0 Comentários
0 Compartilhamentos
543 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Clinical Development Challenges in Tablet and Capsule ManufacturingTablets and capsules remain the gold standard in oral drug delivery, prized for their patient compliance, manufacturing scalability, and precise dosing. However, beneath their familiar exterior lies a complex developmental journey. Transitioning a novel molecule or a complex generic formulation from the benchtop into scalable, commercial-grade solid oral dosage forms is fraught with scientific,...0 Comentários 0 Compartilhamentos 699 Visualizações 0 Anterior
-
Clinical Nutrition Market Growth to Witness Astonishing Development during Forecast Analysis By Fact.MRNew York / London, August 12, 2026 — The global clinical nutrition market is estimated at US$ 15.48 billion in 2024 and is projected to reach US$ 25.94 billion by 2034, expanding at a compound annual growth rate (CAGR) of 5.3%. Note: The source report also states a 2025 value of USD 16.30 billion rising to USD 28.76 billion by 2036 at the same 5.3% CAGR (adding USD 11.60...0 Comentários 0 Compartilhamentos 552 Visualizações 0 Anterior
-
Clinical Operations and Development Market Revenue Projected to Reach USD 176.29 Billion by 2034The Clinical Operations and Development Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Clinical Operations and Development Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive...0 Comentários 0 Compartilhamentos 506 Visualizações 0 Anterior
-
Clinical Research and Combination Therapies Influence Future IHD Drug DevelopmentResearch into ischemic heart disease continues to focus on improving cardiovascular outcomes, reducing complications, and addressing the needs of different patient populations. The condition involves complex interactions among coronary circulation, blood clotting, cholesterol, inflammation, and other cardiovascular processes. Pharmaceutical development therefore includes several therapeutic...0 Comentários 0 Compartilhamentos 98 Visualizações 0 Anterior
-
Clinical Trials Outsourcing Market Size, Share, and Growth Forecast: Trends Shaping Drug DevelopmentThe Clinical Trials Outsourcing Market has emerged as a vital component of the global pharmaceutical and biotechnology industries. As drug development becomes more complex and costly, pharmaceutical companies are increasingly partnering with specialized service providers to manage clinical research activities. Outsourcing clinical trials helps organizations reduce operational costs,...0 Comentários 0 Compartilhamentos 641 Visualizações 0 Anterior
-
Decentralized Clinical Trials Are Changing Drug Development: Market to Reach USD 15.61 Billion by 2034Clinical trials are the backbone of medical progress, but traditional trials can be slow, costly and difficult for patients to join. Participants often need to travel long distances to research sites, take time off work and attend frequent in-person visits. These barriers contribute to recruitment delays, high dropout rates and trial populations that do not reflect the diversity of real-world...0 Comentários 0 Compartilhamentos 92 Visualizações 0 Anterior
-
Decentralized Clinical Trials Contract Research Organization CRO Market Growth, Excellent Development of Fintech Block Chain with Key Vendors Analysis By Fact.MRROCKVILLE, MARYLAND , August 8, 2026 – The decentralized clinical trials contract research organization (CRO) market reached USD 7.9 billion in 2025. Demand is projected to increase from USD 8.7 billion in 2026 to USD 23.4 billion by 2036, recording a 10.4% CAGR and creating a USD 14.7 billion absolute opportunity between 2026 and 2036. Get detailed market forecasts,...0 Comentários 0 Compartilhamentos 997 Visualizações 0 Anterior
-
From Preclinical Studies to Clinical Development: Building an Efficient Drug Development StrategyThe journey of a novel therapeutic molecule from an initial discovery concept to a commercially viable pharmaceutical product is one of the most complex, resource-intensive, and strictly regulated endeavors in modern science. Historically, the drug development lifecycle has been characterized by high attrition rates, escalating costs, and lengthy timelines. A critical factor separating...0 Comentários 0 Compartilhamentos 789 Visualizações 0 Anterior
-
Functional Service Providers Market – Flexible Resourcing Transforming Clinical DevelopmentMarket Overview The Functional Service Providers Market is expanding rapidly as pharmaceutical and biotechnology companies seek flexible, cost-efficient alternatives to traditional full-service contract research organization engagements. FSP models allow sponsors to outsource specific functional areas such as biostatistics, data management, or clinical monitoring while retaining strategic...0 Comentários 0 Compartilhamentos 411 Visualizações 0 Anterior
-
Global Veterinary Clinical Trials Market Trends Driving Animal Drug DevelopmentPolaris Market Research announces the release of its latest research report Veterinary Clinical Trials Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve...0 Comentários 0 Compartilhamentos 358 Visualizações 0 Anterior
-
HDAC Inhibitor Market Trends in Drug Discovery, Clinical Research, and Development to 2034HDAC Inhibitor Market is supported by increasing pharmaceutical research expenditure. Investment in innovative cancer therapies is encouraging the discovery and evaluation of epigenetic medicines for diseases with limited treatment options. The HDAC Inhibitor Market was valued at US$ 1.42 billion in 2025 and is projected to reach US$ 2.65 billion by 2034, registering a CAGR of 7.18% during...0 Comentários 0 Compartilhamentos 421 Visualizações 0 Anterior
-
Biosimulation Market Demand Rises With Growing Focus on Precision Drug DevelopmentA drug candidate can spend years moving through discovery, preclinical testing, and clinical development before researchers know whether it will ultimately succeed. That uncertainty is one of the central problems that the Biosimulation Market is increasingly addressing. Instead of relying entirely on physical experiments to understand how a drug may behave, researchers can use...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
The Rise of Autonomous Healthcare Robots in Modern Hospital Service SystemsThe healthcare industry is undergoing a significant transformation with the integration of autonomous mobile robots, which are revolutionizing how hospitals and healthcare facilities operate. These robots are designed to perform a variety of tasks, from delivering medications and supplies to disinfecting patient rooms, thereby improving operational efficiency and patient safety....0 Comentários 0 Compartilhamentos 13K Visualizações 0 Anterior
-
AI Clinical Trial Market Growing at 15% CAGR Through 2034According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Biosimulation Market Expansion and the Rising Role of Predictive AnalyticsA drug candidate can spend years moving through discovery, preclinical testing, and clinical development before researchers know whether it will ultimately succeed. That uncertainty is one of the central problems that the Biosimulation Market is increasingly addressing. Instead of relying entirely on physical experiments to understand how a drug may behave, researchers can use computational...0 Comentários 0 Compartilhamentos 656 Visualizações 0 Anterior
-
Global CRO Market Trends: Key Growth Drivers, Challenges, and OpportunitiesContract Research Organization Market to Grow at 9.7% CAGR, Reaching USD 179.4 Billion by 2033 Overview M2Square Consultancy estimates that the global Contract Research Organization (CRO) Market was valued at USD 88.3 billion in 2025 and is projected to reach USD 179.4 billion by 2033, expanding at a compound annual growth rate (CAGR) of 9.7% during the forecast period. Contract research...0 Comentários 0 Compartilhamentos 744 Visualizações 0 Anterior
-
Ionis (IONS) partner Roche shows sefaxersen cut IgA nephropathy proteinuria 43.1% in Phase 3Roche gave the first effect size from its IMAgINATION kidney trial at ASN Kidney Week, a clearer read for Ionis Pharmaceuticals Inc. (IONS) on a partnered drug that carries milestones and royalties. Sefaxersen cut proteinuria by 43.1% against placebo at 37 weeks in a Phase 3 trial in IgA nephropathy, according to data Ionis Pharmaceuticals Inc. (IONS) released on October 23. Roche Holding AG,...0 Comentários 0 Compartilhamentos 809 Visualizações 0 Anterior
-
The Oncology Clinical Trials Ecosystem: Market Dynamics and Competitive StrategiesThe global Oncology Clinical Development Market is expanding as pharmaceutical and biotechnology companies increase investment in cancer drug development, biomarker-driven trials, and specialized clinical research services. According to Future Market Insights (FMI), the market is projected to grow from USD 1.5 billion in 2026 to USD 4.2 billion by 2036, registering a 10.7% CAGR during the...0 Comentários 0 Compartilhamentos 476 Visualizações 0 Anterior
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek